🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a multicenter, multinational, open-label, one-way cross-over, Phase...
Status
Active Not Recruiting
Location
Center for Inherited Blood Disorders (CIBD) Site Number : 8400012
Start Date
2023-02-01
Trial ID
NCT05662319
This is a non-interventional, multicenter, observational, international stu...
Status
Recruiting
Location
Arthur M. Blank Hospital
Start Date
2020-03-17
Trial ID
NCT04023019
The objective of this study is to assess whether prophylactic therapy with ...
Status
Completed
Location
Tulane University School of Medicine
Start Date
2003-06
Trial ID
NCT00221195
Treatments Being Tested
Hemophilia A is a severe, life-long, genetic bleeding disorder characterize...
Status
Active Not Recruiting
Location
Childrens Hospital Los Angeles
Start Date
2020-07-01
Trial ID
NCT04205175
Treatments Being Tested
The purpose of this pilot study is to evaluate the feasibility of the proph...
Status
Completed
Location
Oregon Health and Science University
Start Date
2016-02
Trial ID
NCT02577614
Treatments Being Tested
This trial is conducted in the United States of America (USA). This study c...
Status
Completed
Location
Novo Nordisk Investigational Site
Start Date
2001-09
Trial ID
NCT00108797
Treatments Being Tested
This study aims to evaluate the immunomodulatory effect of FEIBA® in patien...
Status
Unknown
Location
University Hospital La Paz
Start Date
2014-01
Trial ID
NCT02018393
The purpose of this research is to understand if the medication called FEIB...
Status
Withdrawn
Location
Multiple Locations
Start Date
2021-10
Trial ID
NCT05020483
This study aims to assess a fixed-dose regimen of activated prothrombin com...
Status
Completed
Location
Multiple Locations
Start Date
2015-10
Trial ID
NCT02565836
The goal of this observational study is to assess if the version A of the H...
Status
Completed
Location
Institute of Hematology and Blood Transfusion
Start Date
2024-03-26
Trial ID
NCT06357572